SEC Form 4 · accession 0001140361-15-045654
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Abdun-Nabi
Officer — President & CEO · Director
Period of report
Dec 23, 2015
Accepted (ET)
Dec 28, 2015 · 2:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 23, 2015 | M | 40,354 | $18.90 | A | 225,722 | D | |
| Common StockF1,F2,F3 | Dec 23, 2015 | S | 40,354 | $38.99 | D | 185,368 | D | |
| Common StockF1 | Dec 24, 2015 | M | 22,855 | $18.90 | A | 208,223 | D | |
| Common StockF1,F2,F4 | Dec 24, 2015 | S | 22,855 | $39.17 | D | 185,368 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1,F5 | $18.90 | Dec 23, 2015 | M | 40,354 | D | — | Mar 9, 2019 | Common Stock | 40,354 | 22,855 | D |
| Stock OptionF1,F5 | $18.90 | Dec 24, 2015 | M | 22,855 | D | — | Mar 9, 2019 | Common Stock | 22,855 | 0 | D |
Explanation of responses
- F1Consists of an option granted under the company's stock incentive plan on March 10, 2009.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi.
- F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.79 to $39.11, inclusive.
- F4The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.99 to $39.48, inclusive.
- F5The option vested in three equal installments in March 2010, 2011 and 2012.